Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Morten Persson"'
Autor:
Rasmus Ingemann Tuffveson Jensen, Joras Ferwerda, Kristian Sand Jørgensen, Erik Rathje Jensen, Martin Borg, Morten Persson Krogh, Jonas Brunholm Jensen, Alexandros Iosifidis
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-10 (2023)
Abstract Bank transactions are highly confidential. As a result, there are no real public data sets that can be used to investigate and compare anti-money laundering (AML) methods in banks. This severely limits research on important AML problems such
Externí odkaz:
https://doaj.org/article/0258148f42b7478895bea05df3b4d013
Autor:
Anders Christensen, Katalin Kiss, Giedrius Lelkaitis, Karina Juhl, Morten Persson, Birgitte Wittenborg Charabi, Jann Mortensen, Julie Lyng Forman, Anne Lyngholm Sørensen, David Hebbelstrup Jensen, Andreas Kjaer, Christian von Buchwald
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Tumor-specific biomarkers are a prerequisite for the development of targeted imaging and therapy in oral squamous cell carcinoma (OSCC). urokinase-type Plasminogen Activator Receptor (uPAR), Tissue Factor (TF) and Epidermal Growth
Externí odkaz:
https://doaj.org/article/b41158b344bf45088ebd2694d4a1a92e
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147428 (2016)
Near infrared intra-operative optical imaging is an emerging technique with clear implications for improved cancer surgery by enabling a more distinct delineation of the tumor margins during resection. This modality has the potential to increase the
Externí odkaz:
https://doaj.org/article/7225a4f9bd1e4206bbfa05fbcdbcbab9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
PET Clinics. 12:311-319
Urokinase plasminogen activator receptor (uPAR) is a key component in proteolysis and extracellular matrix degradation during cancer invasion and metastasis. uPAR overexpression is an important biomarker for aggressiveness in several solid tumors and
Autor:
Camilla L. Christensen, Malene Brandt-Larsen, Niels Kroman, Anne Kiil Berthelsen, Klaus Brasso, Helle Pappot, Andreas Kjaer, Thomas Levin Klausen, Morten Persson, Flemming L. Andersen, Søren Holm, Jacob Madsen, Annika Loft, Liselotte Højgaard, Dorthe Skovgaard
Publikováno v:
J Nucl Med
The overexpression of urokinase-type plasminogen activator receptors (uPARs) represents an established biomarker for aggressiveness in most common malignant diseases, including breast cancer (BC), prostate cancer (PC), and urinary bladder cancer (UBC
Autor:
Signe Ingvarsen, Clement S. Trovik, Andreas Hald, Kirstine S Nørregaard, Ole Didrik Laerum, Niels Behrendt, Johan Eide, Morten Persson, Thomas H. Bugge, Henrik J. Jürgensen, Christoffer Nielsen, Daniel H. Madsen, Kristina Johansson, Maria C. Melander, Andreas Kjaer, Lars H. Engelholm
Publikováno v:
The Journal of Pathology. 238:120-133
In osteosarcoma, a primary mesenchymal bone cancer occurring predominantly in younger patients, invasive tumour growth leads to extensive bone destruction. This process is insufficiently understood, cannot be efficiently counteracted and calls for no
Autor:
Anne Kiil Berthelsen, Jacob Madsen, Carsten H. Nielsen, Thomas Levin Klausen, Liselotte Højgaard, Helle Pappot, Tine Thurison, Klaus Brasso, Andreas Kjaer, Dorthe Skovgaard, Niels Kroman, Annika Loft, Camilla L. Christensen, Malene Brandt-Larsen, Michael Ploug, Morten Persson, Søren Holm
Publikováno v:
Theranostics
A first-in-human clinical trial with Positron Emission Tomography (PET) imaging of the urokinase-type plasminogen activator receptor (uPAR) in patients with breast, prostate and bladder cancer, is described. uPAR is expressed in many types of human c
Autor:
Karina Juhl, Julie Lyng Forman, Birgitte Charabi, Andreas Kjaer, Katalin Kiss, Anders S. Christensen, David Hebbelstrup Jensen, Jann Mortensen, Anne Lyngholm Sørensen, Morten Persson, Christian von Buchwald, Giedrius Lelkaitis
Publikováno v:
Christensen, A, Kiss, K, Lelkaitis, G, Juhl, K, Persson, M, Charabi, B W, Mortensen, J, Forman, J L, Sørensen, A L, Jensen, D H, Kjaer, A & von Buchwald, C 2017, ' Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR) : tumor expression patterns and prognostic value in oral cancer ', BMC Cancer, vol. 17, 572 . https://doi.org/10.1186/s12885-017-3563-3
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
BMC Cancer
Background Tumor-specific biomarkers are a prerequisite for the development of targeted imaging and therapy in oral squamous cell carcinoma (OSCC). urokinase-type Plasminogen Activator Receptor (uPAR), Tissue Factor (TF) and Epidermal Growth Factor R
Publikováno v:
PET clinics. 12(3)
Urokinase plasminogen activator receptor (uPAR) is a key component in proteolysis and extracellular matrix degradation during cancer invasion and metastasis. uPAR overexpression is an important biomarker for aggressiveness in several solid tumors and